Osmotic Demyelination Syndrome With Evolving Movement Disorders

JAMA Neurol. 2018 Jul 1;75(7):888-889. doi: 10.1001/jamaneurol.2018.0983.

Authors

Ai Huey Tan¹, Shen-Yang Lim¹, Rong Xiang Ng²

Affiliations

¹ Division of Neurology and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, University of Malaya, Kuala Lumpur, Malaysia.
² Department of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.

PMID: 29799978
DOI: 10.1001/jamaneurol.2018.0983

No abstract available

Publication types

Case Reports
Video-Audio Media

MeSH terms

Acute Disease
Adult
Akinetic Mutism / drug therapy
Akinetic Mutism / etiology*
Athetosis / etiology*
Benserazide / therapeutic use
Chorea / etiology*
Demyelinating Diseases / drug therapy
Demyelinating Diseases / etiology
Dopamine Agents / therapeutic use
Drug Combinations
Fluid Therapy / adverse effects*
Gastroenteritis / complications
Humans
Hyponatremia / etiology
Hyponatremia / therapy*
Levodopa / therapeutic use
Male
Myelinolysis, Central Pontine
Parkinsonian Disorders / drug therapy
Parkinsonian Disorders / etiology*
Saline Solution / administration & dosage*
Time Factors

Substances

Dopamine Agents
Drug Combinations
Saline Solution
benserazide, levodopa drug combination
Levodopa
Benserazide